To determine whether HLA-A,B antigens on platelets are integral membrane constituents or simply represent adsorbed plasma proteins, the degree to which they are adsorbed, and the relative ease with which they elute off platelet membranes was studied using various treatments known to elute passively adsorbed membrane proteins. In addition, this question was investigated at the RNA level using phytohemagglutinin stimulation to determine whether platelets have the capacity to respond with de-novo synthesis of HLA antigens and by enzymatic amplification of platelet derived mRNA to attempt to demonstrate the presence of nascent message encoding for these antigens. HLA antigen present on platelet membranes did not elute when platelets were incuba...
International audienceBackground: Platelet (PLT) transfusions are an essential treatment for bleedin...
The mol wt of the glycoprotein(s) carrying the PLA1 antigen was examined on platelets. megakaryocyte...
The immune processes involved in the development of alloantibodies against the human platelet antige...
After reviewing the literature (1-83) , I concluded that: 1) the variable expression of class I HLA ...
An understanding of the mechanisms whereby platelets become susceptible to immunoinjury in vivo ulti...
The very late activation antigens (VLA) are a subset of the superfamily of cell surface glycoprotein...
Human platelets respond to various macromolecules in the plasma. Uptake of specific ligands, and ant...
Abstract. The precise pathogenic mechanism of platelet destruction in immune thrombocytopenias is no...
[[abstract]]Human platelets in three physiological states were prepared. These states were the gel-f...
Patients with low platelet counts or dysfunctional platelets are often treated with platelet transfu...
H-2 antigens are expressed in substantial amounts on murine blood platelets (for H-2 antigenic conte...
We have previously described a series of monoclonal antibodies against platelet membrane glycoprotei...
Human blood platelets were challenged sequen-tially in vitro with polyclonal anti-platelet anti-bodi...
HLA‐Alloimmunization remains a significant problem in platelet transfusion therapy. HLA‐eluted plate...
We describe a new procedure for isolation of glycoproteins IIb (GPIIb) and IIIa (GPIIIa) from human ...
International audienceBackground: Platelet (PLT) transfusions are an essential treatment for bleedin...
The mol wt of the glycoprotein(s) carrying the PLA1 antigen was examined on platelets. megakaryocyte...
The immune processes involved in the development of alloantibodies against the human platelet antige...
After reviewing the literature (1-83) , I concluded that: 1) the variable expression of class I HLA ...
An understanding of the mechanisms whereby platelets become susceptible to immunoinjury in vivo ulti...
The very late activation antigens (VLA) are a subset of the superfamily of cell surface glycoprotein...
Human platelets respond to various macromolecules in the plasma. Uptake of specific ligands, and ant...
Abstract. The precise pathogenic mechanism of platelet destruction in immune thrombocytopenias is no...
[[abstract]]Human platelets in three physiological states were prepared. These states were the gel-f...
Patients with low platelet counts or dysfunctional platelets are often treated with platelet transfu...
H-2 antigens are expressed in substantial amounts on murine blood platelets (for H-2 antigenic conte...
We have previously described a series of monoclonal antibodies against platelet membrane glycoprotei...
Human blood platelets were challenged sequen-tially in vitro with polyclonal anti-platelet anti-bodi...
HLA‐Alloimmunization remains a significant problem in platelet transfusion therapy. HLA‐eluted plate...
We describe a new procedure for isolation of glycoproteins IIb (GPIIb) and IIIa (GPIIIa) from human ...
International audienceBackground: Platelet (PLT) transfusions are an essential treatment for bleedin...
The mol wt of the glycoprotein(s) carrying the PLA1 antigen was examined on platelets. megakaryocyte...
The immune processes involved in the development of alloantibodies against the human platelet antige...